Jacobs Levy Equity Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Buy |
145,298
+89,846
| +162% | +$453K | ﹤0.01% | 816 |
|
|
2025
Q1 | $359K | Buy |
+55,452
| New | +$359K | ﹤0.01% | 959 |
|
|
2024
Q4 | – | Sell |
-350,265
| Closed | -$2.62M | – | 1050 |
|
|
2024
Q3 | $2.62M | Buy |
350,265
+33,473
| +11% | +$251K | 0.01% | 551 |
|
|
2024
Q2 | $2.82M | Buy |
316,792
+6,701
| +2% | +$59.6K | 0.01% | 545 |
|
|
2024
Q1 | $3.14M | Buy |
310,091
+16,615
| +6% | +$168K | 0.01% | 516 |
|
|
2023
Q4 | $2.95M | Buy |
293,476
+12,876
| +5% | +$130K | 0.01% | 536 |
|
|
2023
Q3 | $2.63M | Buy |
+280,600
| New | +$2.63M | 0.02% | 518 |
|
|
2022
Q4 | – | Sell |
-19,169
| Closed | -$370K | – | 1045 |
|
|
2022
Q3 | $370K | Buy |
+19,169
| New | +$370K | ﹤0.01% | 870 |
|